BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinclair K, Dudley E. Metabolomics and Biomarker Discovery. Adv Exp Med Biol 2019;1140:613-33. [PMID: 31347075 DOI: 10.1007/978-3-030-15950-4_37] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Gao Z, Zhou W. Mass spectrometry-based quantitation combined with time-dependent metabolomics to discover metabolic features in human neurogenesis using neural constructs generated from neural progenitor cells. Analyst 2023;148:609-17. [PMID: 36594636 DOI: 10.1039/d2an01162j] [Reference Citation Analysis]
2 Chen X, Zhang H, Xiao B. C9orf16 represents the aberrant genetic programs and drives the progression of PDAC. BMC Cancer 2022;22:1102. [DOI: 10.1186/s12885-022-10202-5] [Reference Citation Analysis]
3 Zhang M, Yang H. Perspectives from metabolomics in the early diagnosis and prognosis of gestational diabetes mellitus. Front Endocrinol 2022;13:967191. [DOI: 10.3389/fendo.2022.967191] [Reference Citation Analysis]
4 Beyoğlu D, Simillion C, Storni F, De Gottardi A, Idle JR. A Metabolomic Analysis of Cirrhotic Ascites. Molecules 2022;27:3935. [PMID: 35745058 DOI: 10.3390/molecules27123935] [Reference Citation Analysis]
5 Reçber T, Çelebier M. An Overview of Food Metabolomics: CE-MS Based Targeted and Non-targeted Analysis. Current and Future Developments in Food Science 2022. [DOI: 10.2174/9789815036152122020017] [Reference Citation Analysis]
6 Han X, Wang J, Gu H, Liao X, Jiang M. Predictive value of liver cirrhosis using metabolite biomarkers of bile acid in the blood: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28529. [PMID: 35089190 DOI: 10.1097/MD.0000000000028529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Llambrich M, Correig E, Gumà J, Brezmes J, Cumeras R. Amanida: an R package for meta-analysis of metabolomics non-integral data. Bioinformatics 2022;38:583-5. [PMID: 34406360 DOI: 10.1093/bioinformatics/btab591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Beyoğlu D, Idle JR. Metabolic Rewiring and the Characterization of Oncometabolites. Cancers (Basel) 2021;13:2900. [PMID: 34200553 DOI: 10.3390/cancers13122900] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
9 Bourdon M, Santulli P, Kateb F, Pocate-Cheriet K, Batteux F, Maignien C, Chouzenoux S, Bordonne C, Marcellin L, Bertho G, Chapron C. Adenomyosis is associated with specific proton nuclear magnetic resonance (1H-NMR) serum metabolic profiles. Fertil Steril 2021;116:243-54. [PMID: 33849709 DOI: 10.1016/j.fertnstert.2021.02.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Qian G, Xu L, Qin J, Huang H, Zhu L, Tang Y, Li X, Ma J, Ma Y, Ding Y, Lv H. Leukocyte proteomics coupled with serum metabolomics identifies novel biomarkers and abnormal amino acid metabolism in Kawasaki disease. J Proteomics 2021;239:104183. [PMID: 33737236 DOI: 10.1016/j.jprot.2021.104183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Pieters A, Gijbels E, Cogliati B, Annaert P, Devisscher L, Vinken M. Biomarkers of cholestasis. Biomark Med 2021;15:437-54. [PMID: 33709780 DOI: 10.2217/bmm-2020-0691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Belhaj MR, Lawler NG, Hoffman NJ. Metabolomics and Lipidomics: Expanding the Molecular Landscape of Exercise Biology. Metabolites 2021;11:151. [PMID: 33799958 DOI: 10.3390/metabo11030151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
13 Zhang WH, Wang WQ, Han X, Gao HL, Li TJ, Xu SS, Li S, Xu HX, Li H, Ye LY, Lin X, Wu CT, Long J, Yu XJ, Liu L. Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective. Comput Struct Biotechnol J 2020;18:3606-14. [PMID: 33304458 DOI: 10.1016/j.csbj.2020.11.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
14 Wang Y, Shao T, Wang J, Huang X, Deng X, Cao Y, Zhou M, Zhao C. An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage. Biomed Pharmacother 2021;133:110991. [PMID: 33227713 DOI: 10.1016/j.biopha.2020.110991] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
15 Beyoğlu D, Idle JR. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020;10:E50. [PMID: 32012846 DOI: 10.3390/metabo10020050] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]